Repeating the last declared payment 4 times a year (its usual pace) works out to a forward annual dividend of $1.36, a 0.54% forward yield at today’s price.
Across the full calendar years shown, the annual payout grew by roughly 12.0% a year.
The payout has held steady or grown for 9 straight full years on file (its entire record here).
| Ex-date | Pay date | Amount |
|---|---|---|
| 15 Sep 2026 | 30 Sep 2026 | $0.34 |
| 15 Jun 2026 | 30 Jun 2026 | $0.34 |
| 16 Mar 2026 | 31 Mar 2026 | $0.34 |
| 5 Dec 2025 | 19 Dec 2025 | $0.31 |
| 15 Sep 2025 | 30 Sep 2025 | $0.31 |
| 13 Jun 2025 | 30 Jun 2025 | $0.31 |
| 14 Mar 2025 | 31 Mar 2025 | $0.31 |
| 6 Dec 2024 | 20 Dec 2024 | $0.28 |
| 16 Sep 2024 | 30 Sep 2024 | $0.28 |
| 14 Jun 2024 | 28 Jun 2024 | $0.28 |
| 7 Mar 2024 | 28 Mar 2024 | $0.28 |
| 7 Dec 2023 | 22 Dec 2023 | $0.25 |
| 13 Sep 2023 | 29 Sep 2023 | $0.25 |
| 9 Jun 2023 | 30 Jun 2023 | $0.25 |
| 9 Mar 2023 | 31 Mar 2023 | $0.25 |
| 6 Dec 2022 | 23 Dec 2022 | $0.22 |
| 13 Sep 2022 | 30 Sep 2022 | $0.22 |
| 9 Jun 2022 | 30 Jun 2022 | $0.22 |
| 9 Mar 2022 | 31 Mar 2022 | $0.22 |
| 7 Dec 2021 | 24 Dec 2021 | $0.20 |
| 13 Sep 2021 | 30 Sep 2021 | $0.20 |
| 11 Jun 2021 | 30 Jun 2021 | $0.20 |
| 12 Mar 2021 | 31 Mar 2021 | $0.20 |
| 4 Dec 2020 | 24 Dec 2020 | $0.18 |
| 11 Sep 2020 | 30 Sep 2020 | $0.18 |
| 11 Jun 2020 | 30 Jun 2020 | $0.18 |
| 12 Mar 2020 | 31 Mar 2020 | $0.18 |
| 5 Dec 2019 | 20 Dec 2019 | $0.14 |
| 13 Sep 2019 | 30 Sep 2019 | $0.14 |
| 13 Jun 2019 | 28 Jun 2019 | $0.14 |
| 14 Mar 2019 | 29 Mar 2019 | $0.14 |
| 6 Dec 2018 | 21 Dec 2018 | $0.14 |
| 13 Sep 2018 | 28 Sep 2018 | $0.14 |
| 14 Jun 2018 | 29 Jun 2018 | $0.14 |
| 15 Mar 2018 | 29 Mar 2018 | $0.14 |
| 5 Dec 2017 | 20 Dec 2017 | $0.09 |
| 14 Sep 2017 | 29 Sep 2017 | $0.09 |
| 14 Jun 2017 | 30 Jun 2017 | $0.09 |
| 15 Mar 2017 | 31 Mar 2017 | $0.09 |
| 5 Dec 2016 | 21 Dec 2016 | $0.09 |
| Effective date | Ratio |
|---|---|
| 2 Jul 2012 | 2→3:1 |
| 22 Dec 2010 | 2→3:1 |
| 28 Nov 2006 | 2→3:1 |
| 1 Mar 2004 | 1→2:1 |
No comments yet — be the first to weigh in on AME.